Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Search by expertise, name or affiliation
The management of the obese diabetic patient
Jeanine Albu
, Nazia Raja-Khan
Research output
:
Contribution to journal
›
Article
›
peer-review
49
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'The management of the obese diabetic patient'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Obese Diabetic Patients
100%
Glycemic Control
44%
Weight Gain
33%
Insulin
22%
Insulin Resistance
22%
Oral Agents
22%
High Dose
11%
Diabetes
11%
Lifestyle Modification
11%
United States
11%
Pharmacological Therapy
11%
Type 2 Diabetes Mellitus (T2DM)
11%
Weight Control
11%
Weight Reduction
11%
Orlistat
11%
Sibutramine
11%
Diabetic
11%
Obese Patients
11%
Diabetic Patients
11%
Monotherapy
11%
Bariatric Surgery
11%
Vascular Complications
11%
Effective Treatment
11%
Exogenous Insulin
11%
Morbid Obesity
11%
Reducing Agent
11%
Termbase
11%
Oral Hypoglycemic Agents
11%
Obesity Prevalence
11%
Gastric Bypass
11%
Massive Weight Loss
11%
Diabetes Prevalence
11%
Pharmacologic Agents
11%
Vicious Cycle
11%
Glycemia
11%
Insulin Therapy
11%
Cell Dysfunction
11%
Avail
11%
Intensive Glycemic Control
11%
NHANES III
11%
Hypoglycemic Therapy
11%
Kumamoto
11%
Weight Reducing
11%
Explode
11%
UK Prospective Diabetes Study (UKPDS)
11%
Nursing and Health Professions
Diabetic Obesity
100%
Diabetes Mellitus
22%
Insulin Resistance
22%
Drug Megadose
11%
Lifestyle Modification
11%
Prevalence
11%
Disease
11%
Monotherapy
11%
Glucose Blood Level
11%
Non Insulin Dependent Diabetes Mellitus
11%
Gastric Bypass Surgery
11%
Antidiabetic Agent
11%
Insulin Treatment
11%
Body Weight Loss
11%
Bariatric Surgery
11%
National Health and Nutrition Examination Survey
11%
Weight Control
11%
Reducing Agent
11%
Tetrahydrolipstatin
11%
Sibutramine
11%
Pharmacology, Toxicology and Pharmaceutical Science
Diabetic Obesity
100%
Diabetes Mellitus
22%
Insulin Resistance
22%
Disease
11%
Prevalence
11%
Monotherapy
11%
Tetrahydrolipstatin
11%
Sibutramine
11%
Reducing Agent
11%
Antidiabetic Agent
11%
Non Insulin Dependent Diabetes Mellitus
11%